Triaging Neurocognitive Screening After SARS-CoV-2 Infection

Objective neurocognitive measures can provide vital data to inform neurologic workup and should be incorporated as endpoints in clinical trials.
Medscape Medical News

source https://www.medscape.com/viewarticle/968903?src=rss

Comments

Popular posts from this blog

Student Nurses Who Refuse Vaccination Struggle to Complete Degrees

The Clinical Characteristics of Fractures in Pediatric Patients Exposed to Proton Pump Inhibitors